• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Reckson Associates Realty

Reckson Associates Realty

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Johnson & Johnson Looks Overvalued Today

    Third-quarter earnings were ahead of Street expectations, driven mostly by robust growth in the drug division.

  2. InflaRx Announces a $ 55M Series D Financing and Investment Round to Foster its Clinical Stage Complement Anti-C5a Development Programs

    InflaRx Announces a $ 55M Series D Financing and Investment Round to Foster its Clinical Stage Complement Anti-C5a Development Programs

  3. Kowa Pharmaceuticals America, Inc. Announces Court Decision to Uphold Patent Protection for Livalo® (pitavastatin calcium)

    Kowa Pharmaceuticals America, Inc. Announces Court Decision to Uphold Patent Protection for Livalo® (pitavastatin calcium)

  4. Rockwell Automation Demonstrates Commitment to Houston

    Rockwell Automation Demonstrates Commitment to Houston

  5. Galen US Inc. Acquires First Inhaled Therapy Approved to Treat Agitation Associated with Schizophrenia and Bipolar I Disorder, Announces Revised Labeling

    Galen US Inc. Acquires First Inhaled Therapy Approved to Treat Agitation Associated with Schizophrenia and Bipolar I Disorder, Announces Revised Labeling

12345

©2017 Morningstar Advisor. All right reserved.